Time to stop progesterone receptor testing in breast cancer management.
Olivotto
Ivo A
IA
Truong
Pauline T
PT
Speers
Caroline H
CH
Bernstein
Vanessa
V
Allan
Sharon J
SJ
Kelly
Seamus J
SJ
Lesperance
Mary L
ML
D001943:Breast Neoplasms / Q000473:pathology* / Q000628:therapy*; D003362:Cost-Benefit Analysis; D003657:Decision Making; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D008875:Middle Aged; D009362:Neoplasm Metastasis; D009367:Neoplasm Staging / Q000191:economics / Q000379:methods*; D010347:Patient Care Planning; D011237:Predictive Value of Tests; D011379:Prognosis; D011980:Receptors, Progesterone / Q000032:analysis*
D011980:Receptors, Progesterone